市販用(OTC)鎮痛薬の世界市場2023~2027

■ 英語タイトル:Global Over the Counter (OTC) Analgesics Market 2023-2027

調査会社Technavio社が発行したリサーチレポート(データ管理コード:IRTNTR43442-23)■ 発行会社/調査会社:Technavio
■ 商品コード:IRTNTR43442-23
■ 発行日:2023年10月5日
■ 調査対象地域:北米、ヨーロッパ、アジア、その他地域
■ 産業分野:医薬品
■ ページ数:約120
■ レポート言語:英語
■ レポート形式:PDF
■ 納品方式:Eメール(受注後24時間以内)
■ 販売価格オプション(消費税別)
Single User(1名様閲覧用)USD2,500 ⇒換算¥380,000見積依頼/購入/質問フォーム
Enterprise License(同一法人内共有可)USD4,000 ⇒換算¥608,000見積依頼/購入/質問フォーム
販売価格オプションの説明はこちらで、ご購入に関する詳細案内はご利用ガイドでご確認いただけます。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※Eメールによる納品の場合、通常ご注文当日~2日以内に納品致します。
※レポート納品後、納品日+5日以内に請求書を発行・送付致します。(請求書発行日より2ヶ月以内の銀行振込条件、カード払いも可能)
Technavio社の概要及び新刊レポートはこちらでご確認いただけます。

★グローバルリサーチ資料[市販用(OTC)鎮痛薬の世界市場2023~2027]についてメールでお問い合わせはこちら
*** レポート概要(サマリー)***

世界の市販用(OTC)鎮痛薬市場 2023-2027
市販用(OTC)鎮痛薬市場は2022-2027年に6,525.59百万米ドル成長し、予測期間中のCAGRは4.74%で加速すると予測されます。
当レポートでは、市販用(OTC)鎮痛薬市場の全体的な分析、市場規模および予測、動向、成長促進要因、課題に加え、約25のベンダーを網羅したベンダー分析も提供しています。

当レポートでは、現在の市場シナリオ、最新動向と促進要因、市場環境全体に関する最新分析を提供しています。市場は、世界的な高齢化の進展、疼痛関連疾患の有病率の増加、M&A(合併・買収)活動の活発化などが牽引しています。

Technavioの市販用(OTC)鎮痛薬市場は以下のように区分されています:

タイプ別:
- 内服薬
- 外用薬

流通チャネル別:
- オフライン
- オンライン

地域別:
- 北米
- ヨーロッパ
- アジア
- その他の地域(ROW)

本調査では、今後数年間の市販用(OTC)鎮痛薬市場の成長を促進する主な要因の一つとして、市販用(OTC)鎮痛薬の発売数の増加を挙げています。また、OTC医薬品に関するセルフメディケーションや消費者の意識の高まり、e-pharmacyの存在感の高まりは、市場の大きな需要につながるでしょう。

本レポートでは、市販用(OTC)鎮痛薬市場について、以下の分野をカバーしています:
- 市販用(OTC)鎮痛薬市場のサイジング
- 市販用(OTC)鎮痛薬市場予測
- 市販用(OTC)鎮痛薬市場産業分析

本レポートには、AstraZeneca Plc, Bayer AG, Boehringer Ingelheim International GmbH, Cardinal Health Inc., Cipla Ltd., CV Sciences Inc., Endo International Plc, GlaxoSmithKline Plc, Medterra CBD, Novartis AG, Perrigo Co. Plc, Pfizer Inc., Piramal Enterprises Ltd., Reckitt Benckiser Group Plc, Sanofi, Sun Pharmaceutical Industries Ltd., Takeda Pharmaceutical Co. Ltd., Teva Pharmaceutical Industries Ltd., Viatris Inc., Weefsel Pharma, and AKUMSなどの主要企業情報が含まれます。また、市販用(OTC)鎮痛薬市場の分析レポートには、市場成長に影響を与える今後の動向や課題に関する情報も含まれています。これは、企業が戦略を立て、来るべき成長機会をすべて活用するのに役立つものです。

本調査は、産業の主要参加者からのインプットを含め、一次情報と二次情報を客観的に組み合わせて実施しました。
当レポートでは、主要ベンダーの分析に加え、包括的な市場とベンダーの状況を掲載しています。

Technavioは、利益、価格、競争、プロモーションなどの主要パラメータの分析により、複数の情報源からのデータを調査、統合、総括する方法で、市場の詳細な姿を提示しています。また、主要な産業インフルエンサーを特定することで、市場の様々な側面を提示しています。提示されるデータは包括的で信頼性が高く、一次および二次にわたる広範な調査の結果です。市場調査報告書は、正確な市場成長を予測するために、完全な競争環境と、質的・量的調査を用いた綿密なベンダー選定方法と分析を提供します。

1.エグゼクティブサマリー
2.市場状況
3.市場規模
4.過去の市場規模
5.ファイブフォース分析
6.市販用(OTC)鎮痛薬市場のセグメンテーション:種類別
7.市販用(OTC)鎮痛薬市場のセグメンテーション:流通チャネル別
8.顧客状況
9.地理的状況
10.推進要因・課題・傾向
11.企業状況
12.企業分析
13.付録

世界の市場調査レポート販売サイト(H&Iグローバルリサーチ株式会社運営)
*** レポート目次(コンテンツ)***

• 1 Executive Summary
o 1.1 Market overview
o Exhibit 01: Executive Summary €“ Chart on Market Overview
o Exhibit 02: Executive Summary €“ Data Table on Market Overview
o Exhibit 03: Executive Summary €“ Chart on Global Market Characteristics
o Exhibit 04: Executive Summary €“ Chart on Market By Geographical Landscape
o Exhibit 05: Executive Summary €“ Chart on Market Segmentation by Type
o Exhibit 06: Executive Summary €“ Chart on Market Segmentation by Distribution Channel
o Exhibit 07: Executive Summary €“ Chart on Incremental Growth
o Exhibit 08: Executive Summary €“ Data Table on Incremental Growth
o Exhibit 09: Executive Summary €“ Chart on Vendor Market Positioning
• 2 Market Landscape
o 2.1 Market ecosystem
o Exhibit 10: Parent market
o Exhibit 11: Market Characteristics
• 3 Market Sizing
o 3.1 Market definition
o Exhibit 12: Offerings of vendors included in the market definition
o 3.2 Market segment analysis
o Exhibit 13: Market segments
o 3.3 Market size 2022
o 3.4 Market outlook: Forecast for 2022-2027
o Exhibit 14: Chart on Global – Market size and forecast 2022-2027 ($ million)
o Exhibit 15: Data Table on Global – Market size and forecast 2022-2027 ($ million)
o Exhibit 16: Chart on Global Market: Year-over-year growth 2022-2027 (%)
o Exhibit 17: Data Table on Global Market: Year-over-year growth 2022-2027 (%)
• 4 Historic Market Size
o 4.1 Global over the counter analgesics market 2017 – 2021
o Exhibit 18: Historic Market Size €“ Data Table on global over the counter analgesics market 2017 – 2021 ($ million)
o 4.2 Type Segment Analysis 2017 – 2021
o Exhibit 19: Historic Market Size €“ Type Segment 2017 – 2021 ($ million)
o 4.3 Distribution Channel Segment Analysis 2017 – 2021
o Exhibit 20: Historic Market Size €“ Distribution Channel Segment 2017 – 2021 ($ million)
o 4.4 Geography Segment Analysis 2017 – 2021
o Exhibit 21: Historic Market Size €“ Geography Segment 2017 – 2021 ($ million)
o 4.5 Country Segment Analysis 2017 – 2021
o Exhibit 22: Historic Market Size €“ Country Segment 2017 – 2021 ($ million)
• 5 Five Forces Analysis
o 5.1 Five forces summary
o Exhibit 23: Five forces analysis – Comparison between 2022 and 2027
o 5.2 Bargaining power of buyers
o Exhibit 24: Chart on Bargaining power of buyers €“ Impact of key factors 2022 and 2027
o 5.3 Bargaining power of suppliers
o Exhibit 25: Bargaining power of suppliers €“ Impact of key factors in 2022 and 2027
o 5.4 Threat of new entrants
o Exhibit 26: Threat of new entrants €“ Impact of key factors in 2022 and 2027
o 5.5 Threat of substitutes
o Exhibit 27: Threat of substitutes €“ Impact of key factors in 2022 and 2027
o 5.6 Threat of rivalry
o Exhibit 28: Threat of rivalry €“ Impact of key factors in 2022 and 2027
o 5.7 Market condition
o Exhibit 29: Chart on Market condition – Five forces 2022 and 2027
• 6 Market Segmentation by Type
o 6.1 Market segments
o Exhibit 30: Chart on Type – Market share 2022-2027 (%)
o Exhibit 31: Data Table on Type – Market share 2022-2027 (%)
o 6.2 Comparison by Type
o Exhibit 32: Chart on Comparison by Type
o Exhibit 33: Data Table on Comparison by Type
o 6.3 Internal – Market size and forecast 2022-2027
o Exhibit 34: Chart on Internal – Market size and forecast 2022-2027 ($ million)
o Exhibit 35: Data Table on Internal – Market size and forecast 2022-2027 ($ million)
o Exhibit 36: Chart on Internal – Year-over-year growth 2022-2027 (%)
o Exhibit 37: Data Table on Internal – Year-over-year growth 2022-2027 (%)
o 6.4 External – Market size and forecast 2022-2027
o Exhibit 38: Chart on External – Market size and forecast 2022-2027 ($ million)
o Exhibit 39: Data Table on External – Market size and forecast 2022-2027 ($ million)
o Exhibit 40: Chart on External – Year-over-year growth 2022-2027 (%)
o Exhibit 41: Data Table on External – Year-over-year growth 2022-2027 (%)
o 6.5 Market opportunity by Type
o Exhibit 42: Market opportunity by Type ($ million)
o Exhibit 43: Data Table on Market opportunity by Type ($ million)
• 7 Market Segmentation by Distribution Channel
o 7.1 Market segments
o Exhibit 44: Chart on Distribution Channel – Market share 2022-2027 (%)
o Exhibit 45: Data Table on Distribution Channel – Market share 2022-2027 (%)
o 7.2 Comparison by Distribution Channel
o Exhibit 46: Chart on Comparison by Distribution Channel
o Exhibit 47: Data Table on Comparison by Distribution Channel
o 7.3 Offline – Market size and forecast 2022-2027
o Exhibit 48: Chart on Offline – Market size and forecast 2022-2027 ($ million)
o Exhibit 49: Data Table on Offline – Market size and forecast 2022-2027 ($ million)
o Exhibit 50: Chart on Offline – Year-over-year growth 2022-2027 (%)
o Exhibit 51: Data Table on Offline – Year-over-year growth 2022-2027 (%)
o 7.4 Online – Market size and forecast 2022-2027
o Exhibit 52: Chart on Online – Market size and forecast 2022-2027 ($ million)
o Exhibit 53: Data Table on Online – Market size and forecast 2022-2027 ($ million)
o Exhibit 54: Chart on Online – Year-over-year growth 2022-2027 (%)
o Exhibit 55: Data Table on Online – Year-over-year growth 2022-2027 (%)
o 7.5 Market opportunity by Distribution Channel
o Exhibit 56: Market opportunity by Distribution Channel ($ million)
o Exhibit 57: Data Table on Market opportunity by Distribution Channel ($ million)
• 8 Customer Landscape
o 8.1 Customer landscape overview
o Exhibit 58: Analysis of price sensitivity, lifecycle, customer purchase basket, adoption rates, and purchase criteria
• 9 Geographic Landscape
o 9.1 Geographic segmentation
o Exhibit 59: Chart on Market share By Geographical Landscape 2022-2027 (%)
o Exhibit 60: Data Table on Market share By Geographical Landscape 2022-2027 (%)
o 9.2 Geographic comparison
o Exhibit 61: Chart on Geographic comparison
o Exhibit 62: Data Table on Geographic comparison
o 9.3 North America – Market size and forecast 2022-2027
o Exhibit 63: Chart on North America – Market size and forecast 2022-2027 ($ million)
o Exhibit 64: Data Table on North America – Market size and forecast 2022-2027 ($ million)
o Exhibit 65: Chart on North America – Year-over-year growth 2022-2027 (%)
o Exhibit 66: Data Table on North America – Year-over-year growth 2022-2027 (%)
o 9.4 Europe – Market size and forecast 2022-2027
o Exhibit 67: Chart on Europe – Market size and forecast 2022-2027 ($ million)
o Exhibit 68: Data Table on Europe – Market size and forecast 2022-2027 ($ million)
o Exhibit 69: Chart on Europe – Year-over-year growth 2022-2027 (%)
o Exhibit 70: Data Table on Europe – Year-over-year growth 2022-2027 (%)
o 9.5 Asia – Market size and forecast 2022-2027
o Exhibit 71: Chart on Asia – Market size and forecast 2022-2027 ($ million)
o Exhibit 72: Data Table on Asia – Market size and forecast 2022-2027 ($ million)
o Exhibit 73: Chart on Asia – Year-over-year growth 2022-2027 (%)
o Exhibit 74: Data Table on Asia – Year-over-year growth 2022-2027 (%)
o 9.6 Rest of World (ROW) – Market size and forecast 2022-2027
o Exhibit 75: Chart on Rest of World (ROW) – Market size and forecast 2022-2027 ($ million)
o Exhibit 76: Data Table on Rest of World (ROW) – Market size and forecast 2022-2027 ($ million)
o Exhibit 77: Chart on Rest of World (ROW) – Year-over-year growth 2022-2027 (%)
o Exhibit 78: Data Table on Rest of World (ROW) – Year-over-year growth 2022-2027 (%)
o 9.7 US – Market size and forecast 2022-2027
o Exhibit 79: Chart on US – Market size and forecast 2022-2027 ($ million)
o Exhibit 80: Data Table on US – Market size and forecast 2022-2027 ($ million)
o Exhibit 81: Chart on US – Year-over-year growth 2022-2027 (%)
o Exhibit 82: Data Table on US – Year-over-year growth 2022-2027 (%)
o 9.8 Germany – Market size and forecast 2022-2027
o Exhibit 83: Chart on Germany – Market size and forecast 2022-2027 ($ million)
o Exhibit 84: Data Table on Germany – Market size and forecast 2022-2027 ($ million)
o Exhibit 85: Chart on Germany – Year-over-year growth 2022-2027 (%)
o Exhibit 86: Data Table on Germany – Year-over-year growth 2022-2027 (%)
o 9.9 China – Market size and forecast 2022-2027
o Exhibit 87: Chart on China – Market size and forecast 2022-2027 ($ million)
o Exhibit 88: Data Table on China – Market size and forecast 2022-2027 ($ million)
o Exhibit 89: Chart on China – Year-over-year growth 2022-2027 (%)
o Exhibit 90: Data Table on China – Year-over-year growth 2022-2027 (%)
o 9.10 UK – Market size and forecast 2022-2027
o Exhibit 91: Chart on UK – Market size and forecast 2022-2027 ($ million)
o Exhibit 92: Data Table on UK – Market size and forecast 2022-2027 ($ million)
o Exhibit 93: Chart on UK – Year-over-year growth 2022-2027 (%)
o Exhibit 94: Data Table on UK – Year-over-year growth 2022-2027 (%)
o 9.11 Japan – Market size and forecast 2022-2027
o Exhibit 95: Chart on Japan – Market size and forecast 2022-2027 ($ million)
o Exhibit 96: Data Table on Japan – Market size and forecast 2022-2027 ($ million)
o Exhibit 97: Chart on Japan – Year-over-year growth 2022-2027 (%)
o Exhibit 98: Data Table on Japan – Year-over-year growth 2022-2027 (%)
o 9.12 Market opportunity By Geographical Landscape
o Exhibit 99: Market opportunity By Geographical Landscape ($ million)
o Exhibit 100: Data Tables on Market opportunity By Geographical Landscape ($ million)
• 10 Drivers, Challenges, and Trends
o 10.1 Market drivers
o 10.2 Market challenges
o 10.3 Impact of drivers and challenges
o Exhibit 101: Impact of drivers and challenges in 2022 and 2027
o 10.4 Market trends
• 11 Vendor Landscape
o 11.1 Overview
o 11.2 Vendor landscape
o Exhibit 102: Overview on Criticality of inputs and Factors of differentiation
o 11.3 Landscape disruption
o Exhibit 103: Overview on factors of disruption
o 11.4 Industry risks
o Exhibit 104: Impact of key risks on business
• 12 Vendor Analysis
o 12.1 Vendors covered
o Exhibit 105: Vendors covered
o 12.2 Market positioning of vendors
o Exhibit 106: Matrix on vendor position and classification
o 12.3 AstraZeneca Plc
o Exhibit 107: AstraZeneca Plc – Overview
o Exhibit 108: AstraZeneca Plc – Product / Service
o Exhibit 109: AstraZeneca Plc – Key news
o Exhibit 110: AstraZeneca Plc – Key offerings
o 12.4 Bayer AG
o Exhibit 111: Bayer AG – Overview
o Exhibit 112: Bayer AG – Business segments
o Exhibit 113: Bayer AG – Key news
o Exhibit 114: Bayer AG – Key offerings
o Exhibit 115: Bayer AG – Segment focus
o 12.5 Boehringer Ingelheim International GmbH
o Exhibit 116: Boehringer Ingelheim International GmbH – Overview
o Exhibit 117: Boehringer Ingelheim International GmbH – Business segments
o Exhibit 118: Boehringer Ingelheim International GmbH – Key news
o Exhibit 119: Boehringer Ingelheim International GmbH – Key offerings
o Exhibit 120: Boehringer Ingelheim International GmbH – Segment focus
o 12.6 Cipla Ltd.
o Exhibit 121: Cipla Ltd. – Overview
o Exhibit 122: Cipla Ltd. – Business segments
o Exhibit 123: Cipla Ltd. – Key news
o Exhibit 124: Cipla Ltd. – Key offerings
o Exhibit 125: Cipla Ltd. – Segment focus
o 12.7 Endo International Plc
o Exhibit 126: Endo International Plc – Overview
o Exhibit 127: Endo International Plc – Business segments
o Exhibit 128: Endo International Plc – Key news
o Exhibit 129: Endo International Plc – Key offerings
o Exhibit 130: Endo International Plc – Segment focus
o 12.8 GlaxoSmithKline Plc
o Exhibit 131: GlaxoSmithKline Plc – Overview
o Exhibit 132: GlaxoSmithKline Plc – Business segments
o Exhibit 133: GlaxoSmithKline Plc – Key news
o Exhibit 134: GlaxoSmithKline Plc – Key offerings
o Exhibit 135: GlaxoSmithKline Plc – Segment focus
o 12.9 Medterra CBD
o Exhibit 136: Medterra CBD – Overview
o Exhibit 137: Medterra CBD – Product / Service
o Exhibit 138: Medterra CBD – Key offerings
o 12.10 Novartis AG
o Exhibit 139: Novartis AG – Overview
o Exhibit 140: Novartis AG – Business segments
o Exhibit 141: Novartis AG – Key offerings
o Exhibit 142: Novartis AG – Segment focus
o 12.11 Perrigo Co. Plc
o Exhibit 143: Perrigo Co. Plc – Overview
o Exhibit 144: Perrigo Co. Plc – Business segments
o Exhibit 145: Perrigo Co. Plc – Key news
o Exhibit 146: Perrigo Co. Plc – Key offerings
o Exhibit 147: Perrigo Co. Plc – Segment focus
o 12.12 Pfizer Inc.
o Exhibit 148: Pfizer Inc. – Overview
o Exhibit 149: Pfizer Inc. – Product / Service
o Exhibit 150: Pfizer Inc. – Key news
o Exhibit 151: Pfizer Inc. – Key offerings
o 12.13 Reckitt Benckiser Group Plc
o Exhibit 152: Reckitt Benckiser Group Plc – Overview
o Exhibit 153: Reckitt Benckiser Group Plc – Business segments
o Exhibit 154: Reckitt Benckiser Group Plc – Key offerings
o Exhibit 155: Reckitt Benckiser Group Plc – Segment focus
o 12.14 Sanofi
o Exhibit 156: Sanofi – Overview
o Exhibit 157: Sanofi – Business segments
o Exhibit 158: Sanofi – Key news
o Exhibit 159: Sanofi – Key offerings
o Exhibit 160: Sanofi – Segment focus
o 12.15 Sun Pharmaceutical Industries Ltd.
o Exhibit 161: Sun Pharmaceutical Industries Ltd. – Overview
o Exhibit 162: Sun Pharmaceutical Industries Ltd. – Product / Service
o Exhibit 163: Sun Pharmaceutical Industries Ltd. – Key offerings
o 12.16 Takeda Pharmaceutical Co. Ltd.
o Exhibit 164: Takeda Pharmaceutical Co. Ltd. – Overview
o Exhibit 165: Takeda Pharmaceutical Co. Ltd. – Product / Service
o Exhibit 166: Takeda Pharmaceutical Co. Ltd. – Key news
o Exhibit 167: Takeda Pharmaceutical Co. Ltd. – Key offerings
o 12.17 Viatris Inc.
o Exhibit 168: Viatris Inc. – Overview
o Exhibit 169: Viatris Inc. – Business segments
o Exhibit 170: Viatris Inc. – Key news
o Exhibit 171: Viatris Inc. – Key offerings
o Exhibit 172: Viatris Inc. – Segment focus
• 13 Appendix
o 13.1 Scope of the report
o 13.2 Inclusions and exclusions checklist
o Exhibit 173: Inclusions checklist
o Exhibit 174: Exclusions checklist
o 13.3 Currency conversion rates for US$
o Exhibit 175: Currency conversion rates for US$
o 13.4 Research methodology
o Exhibit 176: Research methodology
o Exhibit 177: Validation techniques employed for market sizing
o Exhibit 178: Information sources
o 13.5 List of abbreviations
o Exhibit 179: List of abbreviations

Exhibits:
Exhibits1: Executive Summary €“ Chart on Market Overview
Exhibits2: Executive Summary €“ Data Table on Market Overview
Exhibits3: Executive Summary €“ Chart on Global Market Characteristics
Exhibits4: Executive Summary €“ Chart on Market By Geographical Landscape
Exhibits5: Executive Summary €“ Chart on Market Segmentation by Type
Exhibits6: Executive Summary €“ Chart on Market Segmentation by Distribution Channel
Exhibits7: Executive Summary €“ Chart on Incremental Growth
Exhibits8: Executive Summary €“ Data Table on Incremental Growth
Exhibits9: Executive Summary €“ Chart on Vendor Market Positioning
Exhibits10: Parent market
Exhibits11: Market Characteristics
Exhibits12: Offerings of vendors included in the market definition
Exhibits13: Market segments
Exhibits14: Chart on Global – Market size and forecast 2022-2027 ($ million)
Exhibits15: Data Table on Global – Market size and forecast 2022-2027 ($ million)
Exhibits16: Chart on Global Market: Year-over-year growth 2022-2027 (%)
Exhibits17: Data Table on Global Market: Year-over-year growth 2022-2027 (%)
Exhibits18: Historic Market Size €“ Data Table on global over the counter analgesics market 2017 – 2021 ($ million)
Exhibits19: Historic Market Size €“ Type Segment 2017 – 2021 ($ million)
Exhibits20: Historic Market Size €“ Distribution Channel Segment 2017 – 2021 ($ million)
Exhibits21: Historic Market Size €“ Geography Segment 2017 – 2021 ($ million)
Exhibits22: Historic Market Size €“ Country Segment 2017 – 2021 ($ million)
Exhibits23: Five forces analysis – Comparison between 2022 and 2027
Exhibits24: Chart on Bargaining power of buyers €“ Impact of key factors 2022 and 2027
Exhibits25: Bargaining power of suppliers €“ Impact of key factors in 2022 and 2027
Exhibits26: Threat of new entrants €“ Impact of key factors in 2022 and 2027
Exhibits27: Threat of substitutes €“ Impact of key factors in 2022 and 2027
Exhibits28: Threat of rivalry €“ Impact of key factors in 2022 and 2027
Exhibits29: Chart on Market condition – Five forces 2022 and 2027
Exhibits30: Chart on Type – Market share 2022-2027 (%)
Exhibits31: Data Table on Type – Market share 2022-2027 (%)
Exhibits32: Chart on Comparison by Type
Exhibits33: Data Table on Comparison by Type
Exhibits34: Chart on Internal – Market size and forecast 2022-2027 ($ million)
Exhibits35: Data Table on Internal – Market size and forecast 2022-2027 ($ million)
Exhibits36: Chart on Internal – Year-over-year growth 2022-2027 (%)
Exhibits37: Data Table on Internal – Year-over-year growth 2022-2027 (%)
Exhibits38: Chart on External – Market size and forecast 2022-2027 ($ million)
Exhibits39: Data Table on External – Market size and forecast 2022-2027 ($ million)
Exhibits40: Chart on External – Year-over-year growth 2022-2027 (%)
Exhibits41: Data Table on External – Year-over-year growth 2022-2027 (%)
Exhibits42: Market opportunity by Type ($ million)
Exhibits43: Data Table on Market opportunity by Type ($ million)
Exhibits44: Chart on Distribution Channel – Market share 2022-2027 (%)
Exhibits45: Data Table on Distribution Channel – Market share 2022-2027 (%)
Exhibits46: Chart on Comparison by Distribution Channel
Exhibits47: Data Table on Comparison by Distribution Channel
Exhibits48: Chart on Offline – Market size and forecast 2022-2027 ($ million)
Exhibits49: Data Table on Offline – Market size and forecast 2022-2027 ($ million)
Exhibits50: Chart on Offline – Year-over-year growth 2022-2027 (%)
Exhibits51: Data Table on Offline – Year-over-year growth 2022-2027 (%)
Exhibits52: Chart on Online – Market size and forecast 2022-2027 ($ million)
Exhibits53: Data Table on Online – Market size and forecast 2022-2027 ($ million)
Exhibits54: Chart on Online – Year-over-year growth 2022-2027 (%)
Exhibits55: Data Table on Online – Year-over-year growth 2022-2027 (%)
Exhibits56: Market opportunity by Distribution Channel ($ million)
Exhibits57: Data Table on Market opportunity by Distribution Channel ($ million)
Exhibits58: Analysis of price sensitivity, lifecycle, customer purchase basket, adoption rates, and purchase criteria
Exhibits59: Chart on Market share By Geographical Landscape 2022-2027 (%)
Exhibits60: Data Table on Market share By Geographical Landscape 2022-2027 (%)
Exhibits61: Chart on Geographic comparison
Exhibits62: Data Table on Geographic comparison
Exhibits63: Chart on North America – Market size and forecast 2022-2027 ($ million)
Exhibits64: Data Table on North America – Market size and forecast 2022-2027 ($ million)
Exhibits65: Chart on North America – Year-over-year growth 2022-2027 (%)
Exhibits66: Data Table on North America – Year-over-year growth 2022-2027 (%)
Exhibits67: Chart on Europe – Market size and forecast 2022-2027 ($ million)
Exhibits68: Data Table on Europe – Market size and forecast 2022-2027 ($ million)
Exhibits69: Chart on Europe – Year-over-year growth 2022-2027 (%)
Exhibits70: Data Table on Europe – Year-over-year growth 2022-2027 (%)
Exhibits71: Chart on Asia – Market size and forecast 2022-2027 ($ million)
Exhibits72: Data Table on Asia – Market size and forecast 2022-2027 ($ million)
Exhibits73: Chart on Asia – Year-over-year growth 2022-2027 (%)
Exhibits74: Data Table on Asia – Year-over-year growth 2022-2027 (%)
Exhibits75: Chart on Rest of World (ROW) – Market size and forecast 2022-2027 ($ million)
Exhibits76: Data Table on Rest of World (ROW) – Market size and forecast 2022-2027 ($ million)
Exhibits77: Chart on Rest of World (ROW) – Year-over-year growth 2022-2027 (%)
Exhibits78: Data Table on Rest of World (ROW) – Year-over-year growth 2022-2027 (%)
Exhibits79: Chart on US – Market size and forecast 2022-2027 ($ million)
Exhibits80: Data Table on US – Market size and forecast 2022-2027 ($ million)
Exhibits81: Chart on US – Year-over-year growth 2022-2027 (%)
Exhibits82: Data Table on US – Year-over-year growth 2022-2027 (%)
Exhibits83: Chart on Germany – Market size and forecast 2022-2027 ($ million)
Exhibits84: Data Table on Germany – Market size and forecast 2022-2027 ($ million)
Exhibits85: Chart on Germany – Year-over-year growth 2022-2027 (%)
Exhibits86: Data Table on Germany – Year-over-year growth 2022-2027 (%)
Exhibits87: Chart on China – Market size and forecast 2022-2027 ($ million)
Exhibits88: Data Table on China – Market size and forecast 2022-2027 ($ million)
Exhibits89: Chart on China – Year-over-year growth 2022-2027 (%)
Exhibits90: Data Table on China – Year-over-year growth 2022-2027 (%)
Exhibits91: Chart on UK – Market size and forecast 2022-2027 ($ million)
Exhibits92: Data Table on UK – Market size and forecast 2022-2027 ($ million)
Exhibits93: Chart on UK – Year-over-year growth 2022-2027 (%)
Exhibits94: Data Table on UK – Year-over-year growth 2022-2027 (%)
Exhibits95: Chart on Japan – Market size and forecast 2022-2027 ($ million)
Exhibits96: Data Table on Japan – Market size and forecast 2022-2027 ($ million)
Exhibits97: Chart on Japan – Year-over-year growth 2022-2027 (%)
Exhibits98: Data Table on Japan – Year-over-year growth 2022-2027 (%)
Exhibits99: Market opportunity By Geographical Landscape ($ million)
Exhibits100: Data Tables on Market opportunity By Geographical Landscape ($ million)
Exhibits101: Impact of drivers and challenges in 2022 and 2027
Exhibits102: Overview on Criticality of inputs and Factors of differentiation
Exhibits103: Overview on factors of disruption
Exhibits104: Impact of key risks on business
Exhibits105: Vendors covered
Exhibits106: Matrix on vendor position and classification
Exhibits107: AstraZeneca Plc – Overview
Exhibits108: AstraZeneca Plc – Product / Service
Exhibits109: AstraZeneca Plc – Key news
Exhibits110: AstraZeneca Plc – Key offerings
Exhibits111: Bayer AG – Overview
Exhibits112: Bayer AG – Business segments
Exhibits113: Bayer AG – Key news
Exhibits114: Bayer AG – Key offerings
Exhibits115: Bayer AG – Segment focus
Exhibits116: Boehringer Ingelheim International GmbH – Overview
Exhibits117: Boehringer Ingelheim International GmbH – Business segments
Exhibits118: Boehringer Ingelheim International GmbH – Key news
Exhibits119: Boehringer Ingelheim International GmbH – Key offerings
Exhibits120: Boehringer Ingelheim International GmbH – Segment focus
Exhibits121: Cipla Ltd. – Overview
Exhibits122: Cipla Ltd. – Business segments
Exhibits123: Cipla Ltd. – Key news
Exhibits124: Cipla Ltd. – Key offerings
Exhibits125: Cipla Ltd. – Segment focus
Exhibits126: Endo International Plc – Overview
Exhibits127: Endo International Plc – Business segments
Exhibits128: Endo International Plc – Key news
Exhibits129: Endo International Plc – Key offerings
Exhibits130: Endo International Plc – Segment focus
Exhibits131: GlaxoSmithKline Plc – Overview
Exhibits132: GlaxoSmithKline Plc – Business segments
Exhibits133: GlaxoSmithKline Plc – Key news
Exhibits134: GlaxoSmithKline Plc – Key offerings
Exhibits135: GlaxoSmithKline Plc – Segment focus
Exhibits136: Medterra CBD – Overview
Exhibits137: Medterra CBD – Product / Service
Exhibits138: Medterra CBD – Key offerings
Exhibits139: Novartis AG – Overview
Exhibits140: Novartis AG – Business segments
Exhibits141: Novartis AG – Key offerings
Exhibits142: Novartis AG – Segment focus
Exhibits143: Perrigo Co. Plc – Overview
Exhibits144: Perrigo Co. Plc – Business segments
Exhibits145: Perrigo Co. Plc – Key news
Exhibits146: Perrigo Co. Plc – Key offerings
Exhibits147: Perrigo Co. Plc – Segment focus
Exhibits148: Pfizer Inc. – Overview
Exhibits149: Pfizer Inc. – Product / Service
Exhibits150: Pfizer Inc. – Key news
Exhibits151: Pfizer Inc. – Key offerings
Exhibits152: Reckitt Benckiser Group Plc – Overview
Exhibits153: Reckitt Benckiser Group Plc – Business segments
Exhibits154: Reckitt Benckiser Group Plc – Key offerings
Exhibits155: Reckitt Benckiser Group Plc – Segment focus
Exhibits156: Sanofi – Overview
Exhibits157: Sanofi – Business segments
Exhibits158: Sanofi – Key news
Exhibits159: Sanofi – Key offerings
Exhibits160: Sanofi – Segment focus
Exhibits161: Sun Pharmaceutical Industries Ltd. – Overview
Exhibits162: Sun Pharmaceutical Industries Ltd. – Product / Service
Exhibits163: Sun Pharmaceutical Industries Ltd. – Key offerings
Exhibits164: Takeda Pharmaceutical Co. Ltd. – Overview
Exhibits165: Takeda Pharmaceutical Co. Ltd. – Product / Service
Exhibits166: Takeda Pharmaceutical Co. Ltd. – Key news
Exhibits167: Takeda Pharmaceutical Co. Ltd. – Key offerings
Exhibits168: Viatris Inc. – Overview
Exhibits169: Viatris Inc. – Business segments
Exhibits170: Viatris Inc. – Key news
Exhibits171: Viatris Inc. – Key offerings
Exhibits172: Viatris Inc. – Segment focus
Exhibits173: Inclusions checklist
Exhibits174: Exclusions checklist
Exhibits175: Currency conversion rates for US$
Exhibits176: Research methodology
Exhibits177: Validation techniques employed for market sizing
Exhibits178: Information sources
Exhibits179: List of abbreviations



*** 免責事項 ***
https://www.globalresearch.co.jp/disclaimer/



※注目の調査資料
※当サイト上のレポートデータは弊社H&Iグローバルリサーチ運営のMarketReport.jpサイトと連動しています。
※当市場調査資料(IRTNTR43442-23 )"市販用(OTC)鎮痛薬の世界市場2023~2027" (英文:Global Over the Counter (OTC) Analgesics Market 2023-2027)はTechnavio社が調査・発行しており、H&Iグローバルリサーチが販売します。


◆H&Iグローバルリサーチのお客様(例)◆


※当サイトに掲載していない調査資料も弊社を通してご購入可能ですので、お気軽にご連絡ください。ウェブサイトでは紹介しきれない資料も数多くございます。
※無料翻訳ツールをご利用いただけます。翻訳可能なPDF納品ファイルが対象です。ご利用を希望されるお客様はご注文の時にその旨をお申し出ください。